Results 191 to 199 of about 924 (199)

In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii- calcoaceticus Complex Isolates Collected Globally in 2016 and 2017

Antimicrobial Agents and Chemotherapy, 2020
Sarah M McLeod, Samir H Moussa, Meredith A Hackel   +2 more
exaly  

Beyond resistance: assessing sulbactam-durlobactam’s role in today’s clinical landscape

Expert Review of Anti-infective Therapy
openaire   +2 more sources

Sulbactam Sodium and Durlobactam Sodium

openaire   +1 more source

Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii

Future Microbiology
Sarah M McLeod, John O'Donnell, Navaneeth Narayanan   +2 more
exaly  

In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex

Diagnostic Microbiology and Infectious Disease
Alita A Miller, Patricia A Bradford, Nicole M Carter   +2 more
exaly  

Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests

Journal of Clinical Microbiology
Sarah M McLeod, Nicole M Carter, Michael D Huband   +2 more
exaly  

Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis

ACS Infectious Diseases
Mary Nantongo, David C Nguyen, Christopher R Bethel   +2 more
exaly  

Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration

American Journal of Health-System Pharmacy
Yuwei Shen, Yasmeen abouelhassan, David P Nicolau   +2 more
exaly  

Re: Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates: author's response

Clinical Microbiology and Infection
Christophe Le Terrier, Patrice Nordmann, Laurent Poirel   +2 more
exaly